Intersect ENT (XENT) Tops Q4 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AAPL
2. AMD
3. PLTR
4. CRWD
5. DOX
6. VRTX
7. CHKP
8. BKNG
9. ON
10. EL

Go back to Intersect ENT (XENT) Tops Q4 EPS by 3c

Intersect ENT Reports Fourth Quarter and Full Year 2016 Results

February 28, 2017 4:06 PM EST

Q4 2016 Revenue Increased 29% with Gross Margin of 84%

Full Year 2016 Revenue Increased 28% with Gross Margin of 83%

MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the fourth quarter and year ended December 31, 2016.

Fourth quarter 2016 revenue was $24.2 million, a 29% increase over the fourth quarter 2015. Full year 2016 revenue was $78.7 million, a 28% increase over the full year 2015. Fourth quarter 2016 gross... More